[1] 陈震,吕雄文,李俊,等. 咖啡因对小数急性酒精性肝损伤的保护作用. 安徽医科大学学报,2009,44(3):359-361. [2] 刘旭东,王炳元.日本酒精性肝病研究现状. 实用临床医学,2007,11(3):22. [3] 戴水奇,黄顺玲,张雪红,等.湖南省酒精性肝病流行病学分析.中西医结合肝病杂志,2005,15(2):105. [4] Addolorato G,Ancona C,Capristo E,et al. Metadoxine in the treatment of acute and chronic alcoholism:a review. Int J Immunopathol Pharm,2003,16(3):207-214. [5] Vonghia L,Leggio L,Ferrulli A,et al. Acute alcohol intoxication. Eur J Intern Med,2008,19(8):561-567. [6] Shpilenya LS,Muzychenko AP,Gasbarrini G,et al.Metadoxine in acute alcohol intoxication:a double-blind,randomized,placebo- controlled study. Alcohol Clin Experiment Res,2002,26(3): 340-346. [7] Schaff Z. The value of liver biopsy in chronic hepatitis. Orvosi hetilap,2011,152(22):856-858. [8] Chang B,Sang LX. The role of FoxO4 in the relationship between alcohol-induced intestinal barrier dysfunction and liver injury. Int J Mol Med,2013,31(3):569-576. [9] 中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南.中华肝脏病杂志,2006,14(3):164-166. [10] Wang H,Ma L,Yin Q,et al. Prevalence of alcoholic liver disease and its association with socioeconomic status in north-eastern China. Alcoho Clid Experiment Res 2014,38(4):1035-1041. [11] Felicioli R,Saracchi I,Flagiello M,et al. Effects of pyridoxine- pyrrolidon-carboxylate on hepatic and cerebral ATP levels in ethanol treated rats. Int J Clin Pharmacol,1980,18(6):277-280. [12] Ragusa N,Zito D,Bondi C,et al. Effects of pyridoxine on hepatic tryptophan pyrrolase activity in rat during chronic ethanol administration. Bioch Exp Biol,1980,16(4):391-396. [13] Diaz Martinez MC,Diaz Martinez A,Villamil Salcedo V,et al.Efficacy of metadoxine in the management of acute alcohol intoxication. J Int Med Res,2002,30(1):44-51. [14] Feher J,Lengyel G. A new approach to drug therapy in non-alcoholic steatohepatitis(NASH). J Int Med Res,2004,31(6):537-551. [15] 厉有名.酒精性肝病的发病机制.中华肝脏病杂志,2003,11(11):690-691. [16] Grove J,Daly AK,Bassendine MF,et al. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology,1997,26(1):143-146. [17] 王春妍,范玉强,迟宝荣,等.核因子-κB及其下游因子TNF-α、Bcl-2在急性肝损伤中的作用及机制.世界华人消化杂志,2008,16(25):2804-2808. [18] Valen G,Yan ZQ,Hansson GK. Nuclear factor-kappa B and the heart. J Am Coll Cardiol,2001,38(2):307-314. [19] Watanabe T,Jono H,Han JH,et al. Synergistic activation of NF-kappa B by nontypeable Haemophilus infuenzae and tumor necrosis factor-α. PNAS,2004,101(10):3563-3568. [20] 赵彩彦,丛斌.核因子-κB与酒精性肝病. 国外医学.消化系疾病分册,2002,22(4):230-232. [21] Marcos M,Gonzalez R. Common polymorphisms in interleukin genes(IL4,IL6,IL8 and IL12) are not associated with alcoholic liver disease or alcoholism in Spanish men.Cytokine,2009,45(3):158-161. [22] Naveau S. Plasma levels of soluble tumor necrosis factor receptors p55 and p75 in patients with alcoholic liver disease of increasing severity. J Hepatol,1998,28(5):778-784. [23] Pastor LF,Romero A,Gonzalez-Sarmiento M,et al. 238 G > apolymorphism of tumor necrosis factor alpha gene(TNFA) is associated with alcoholic liver cirrhosis in alcoholic Spanish men.Alcohol Clin Exp Res,2005,29(11):1928-1931. [24] 李海燕,李夏,金向群,等. 黄芩苷对大鼠慢性酒精性肝损伤的影响. 中国实验方剂学杂志,2008,14(6):58-60. [25] Chen YL,Peng HC,Hsieh YC,et al. Epidermal growth factor improved alcohol-induced inflammation in rats.Alcohol,2014,48:701-706. [26] Petrasek J,Bala S,Csak T,et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Investig,2012,122(10):3476-3489. [27] 任红,张定风,贾小平,等. 丙型肝炎患者肿瘤坏死因子和白细胞介素6的水平及意义. 中国免疫学杂志,1992,8(1):50-52. [28] Clarien PA,Carnargo CA. Acute reactant cytokines and neutrophil adhesion after warm ischemia in cirrhotic and noncirrhotic human livers. Hepatology,1996,6(23):1456-1463. |